Wall Street Analysts See a 230.56% Upside in Assertio (ASRT): Can the Stock Really Move This High?

Impact · against what's priced in

Assertio (ASRT) shows strong bullish signals driven by significant analyst price target gaps and positive earnings revisions. While recent momentum has already pushed the price up 28.9%, the consensus target of $38.94 suggests the market is still discounting substantial fundamental upside.

ASRT+0.60: No priced-in read yet

Wall Street Analysts See a 230.56% Upside in Assertio (ASRT): Can the Stock Really Move This High?

What matters in this story

20,370 Bristol Myers Squibb Company $BMY Shares Bought by Apella Capital LLC

Wall Street Analysts See a 230.56% Upside in Assertio (ASRT): Can the Stock Really Move This High?

What matters in this story

20,370 Bristol Myers Squibb Company $BMY Shares Bought by Apella Capital LLC

How each ticker is affected

Track these names every morning.

Implied Volatility Surging for Badger Meter Stock Options

Should Investors Buy Navitas Semiconductor Stock on the Dip?

Is the Upside Worth the Risk in Amazon Stock Right Now in October?

3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead

Wall Street Analysts See a 230.56% Upside in Assertio (ASRT): Can the Stock Really Move This High?

What matters in this story

Next reads from the same story arc

20,370 Bristol Myers Squibb Company $BMY Shares Bought by Apella Capital LLC

Wall Street Analysts See a 230.56% Upside in Assertio (ASRT): Can the Stock Really Move This High?

What matters in this story

Next reads from the same story arc

20,370 Bristol Myers Squibb Company $BMY Shares Bought by Apella Capital LLC

How each ticker is affected

Track these names every morning.

Implied Volatility Surging for Badger Meter Stock Options

Should Investors Buy Navitas Semiconductor Stock on the Dip?

Is the Upside Worth the Risk in Amazon Stock Right Now in October?

3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead